Resources
-
LCMS Assays for mRNA CQAs: A Development Story
Speaker Presentation: Mass Spec 2025
Johnson Alex, Aldevron, LLC, 2025 -
Unraveling the Metabolic Regulatory Mechanisms Driving Product Expression and Quality in CHO Cell Cultures Using a Multi-Omics Approach
Speaker Presentation: Mass Spec 2025
Gorre Elsa, Johnson & Johnson, 2025 -
Employing Electron Activated Dissociation (EAD) fragmentation to identify reactive N-oxide impurities in Lipid Nanoparticles (LNPs)
Speaker Presentation: Mass Spec 2025
Crowe Adam, Cytiva, 2025 -
Rapid Online Buffer Exchange with the DynaChip X1 Platform for Complex Biological Analysis
Speaker Presentation: Mass Spec 2025
Chilmonczyk Mason, Andson Biotech, 2025 -
Expanding MAM Horizon Beyond mAb-Based Therapeutics
Speaker Presentation: Mass Spec 2025
Carillo Sara, NIBRT, 2025 -
New Mass Spec Methods to Tackle New Biotherapeutic Challenges
Roundtable Notes: Session 1 Table 1 Mass Spec 2025
New Mass Spec Methods to Tackle New Biotherapeutic Challenges -
MS-Based Protein Higher Order Structure Characterization in Biologics Research and Development
Roundtable Notes: Session 1 Table 2 Mass Spec 2025
MS-Based Protein Higher Order Structure Characterization in Biologics Research and Development -
MS of RNA and Oligonucleotides - Characterization and Quantitation of CQAs
Roundtable Notes: Session 1 Table 3 Mass Spec 2025
MS of RNA and Oligonucleotides - Characterization and Quantitation of CQAs -
MS for HCP
Roundtable Notes: Session 1 Table 6 Mass Spec 2025
MS for HCP -
Mass Spectrometry & Predictive Stability
Roundtable Notes: Session 1 Table 9 Mass Spec 2025
Mass Spectrometry & Predictive Stability -
Mass Spec in Cell and Gene Therapy
Roundtable Notes: Session 1 Table 4 Mass Spec 2025
Mass Spec in Cell and Gene Therapy -
MAM in Development and in QC
Roundtable Notes: Session 1 Table 7 Mass Spec 2025
MAM in Development and in QC -
Challenges and Obstacles to True Belonging in the Workplace
Roundtable Notes: Session 1 Table 10 Mass Spec 2025
Challenges and Obstacles to True Belonging in the Workplace -
Best Practices of Extended Characterization Mass Spec Methods
Roundtable Notes: Session 1 Table 5 Mass Spec 2025
Best Practices of Extended Characterization Mass Spec Methods -
Best Practices for Elucidating Antibody Drug Conjugates Molecules by MS
Roundtable Notes: Session 1 Table 8 Mass Spec 2025
Best Practices for Elucidating Antibody Drug Conjugates Molecules by MS -
Mass Spec 2025 Summary Infographic
Summary Infographic: Mass Spec 2025
-
Mass Spec 2025 Scientific Program
Scientific Program: Mass Spec 2025
-
Advanced Charge Heterogeneity Profiling of a Model ADC via icIEF Fractionation and Mass Spectrometry
Speaker Presentation: CE Pharm 2025
Zhang Xiaochan, MilliporeSigma, 2025 -
Label-Free Native Fluorescence for High-Sensitivity Protein Analysis Using a Multi-Capillary Electrophoresis System
Speaker Presentation: CE Pharm 2025
Wei Brian, Sanofi, 2025 -
BioPhase 8800 System: Advancing Capillary Electrophoresis with Native Fluorescence Detection
Speaker Presentation: CE Pharm 2025
Wang Fang, SCIEX, 2025